Back
TechTarget Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
45
TTGT
TechTarget
Last Price:
24.63
Seasonality Move:
4.75%
Sell
26
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
45
TechTarget (TTGT)
is a Sell
Is TechTarget a Buy, Sell or Hold?
- The current TechTarget [TTGT] share price is $23.63. The Score for TTGT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- TTGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $55.20. The Score for RARE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TTGT Stock Price Chart
What is TechTarget's stock price today?
-
The TechTarget share price today is $23.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TTGT is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $55.20
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
TTGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.9 | Sell |
Relative Strength Index (14 RSI): | 36.96 | Sell |
Chaikin Money Flow: | 5738 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.91 - 26.49) | Sell |
Bollinger Bands (100): | (26.21 - 31.81) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 46.4 | Sell |
Chaikin Money Flow: | -343486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.94 - 58.24) | Sell |
Bollinger Bands (100): | (40.06 - 53.94) | Buy |
TTGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.46 | Sell |
20-day SMA: | 24.79 | Sell |
50-day SMA: | 27.37 | Sell |
200-day SMA: | 30.55 | Sell |
8-day EMA: | 24.18 | Sell |
20-day EMA: | 24.9 | Sell |
50-day EMA: | 26.67 | Sell |
200-day EMA: | 29.87 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.58 | Sell |
20-day SMA: | 57.08 | Sell |
50-day SMA: | 52.76 | Buy |
200-day SMA: | 46.81 | Buy |
8-day EMA: | 57.09 | Sell |
20-day EMA: | 56.67 | Sell |
50-day EMA: | 53.36 | Buy |
200-day EMA: | 47.25 | Buy |
TechTarget Earnings Growth & TTGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.02 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
TechTarget Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |